| Each
month The Savvy Investor analysts study, research, and examine
hundreds of stocks, in an effort to pinpoint the one with
the most promise.
This
month s pick : TDS Telemedicine, Inc.
Symbol: TDST
Recent Price: $.08
Opinion: Strong
Buy
|
| In
Related News: |
 |
 Health
care providers are getting wired up for a future where every
patient's medical record is a click away and doctors assist
one another in operations thousands of miles apart via video
conferencing. More...
 A
new approach to healthcare around the globe is on its way,
according to experts at the World Economic Forum.. More....
 TDS
Telemedicine CEO Roger Coomber and Chief Medical Officer
Keith Freeman Interviewed.  Video
|
Financial
Analysis
|
 |
| Confirmation has been received for
a total contribution apportioned between County and Medicaid of US
$550,000 in 2003.
With
funding approval in place, as well as anticipated additional
equity funding over the next few months, TDS expects the
following financial performance:
2003 Revenues $1.0 million
Net Pre-tax $100,000
2004 Revenues $13.5 million
Net Pre-tax $3.4 million
2005 Revenues $22.0 million
Net Pre-tax $6.25 million
|
|
| Corporate
Snapshot |
 |
|
TDS Telemedicine Inc is the
parent Company of an established UK based firm,
TDS Dermatology Ltd. For the past 5 years this
Company has provided comprehensive dermatology
telemedicine to the National Health Service in
England. Over 25,000 telemedical
consultations have been performed since the Company
commenced operations, making it the world's largest
telemedical dermatology provider.
The tendency to cut jobs in favor
of profits is a driving force in the economy. When
workers are more productive, fewer workers are
needed. Telemedicine is the logical extension of
this notion as it applies to the health care
industry, a field with the highest concentration of
top paying jobs in the country. Now utilizing
telemedical technology, a single health care
professional can see multiple patients in almost any
location, even in the patients' homes. This means
maximum productivity for medical personnel, lower
capital expenses for the companies that employ them
and the added convenience of "house calls" for the
patients. TDS services will go live later this month in Texas as
planned. Discussions have commenced in other US
states and it is expected that TDST's nationwide roll-out program will
go into effect quickly.
|
|
 |
|
Analyst Conclusion
The
recent SEC ruling to leave the Over The Counter Bulletin
Board in its current form is a very bullish sign for
this market - possibly a turning point. We think that
this is an encouraging signal from regulators that the
OTCBB can expect a more positive financial climate. We
assessed TDST and found 4 basic investment criteria.
1. The market is in
a confirmed rally.
2. TDST is in a leading group.
3. The company financials are strong.
4. TDST is offered at an ideal Buy Point.
I
would expect great things from this company and in my
opinion it is a Strong Buy.
 Editing
Chairman
|
|
